Both in Biotechnology
Fate Therapeutics vs Precision BioSciences
Over the past year FATE returned +75.6% and DTIL returned +21.4%; their daily moves had a correlation of 0.26.
FATE +75.6% DTIL +21.4%Growth of $1, one year, split-adjusted
| Metric | FATE | DTIL |
|---|---|---|
| Price | $2.09 | $8.12 |
| Market cap | $250.4M | $224.1M |
| Today | +2.45% | +16.50% |
| 1 month | −8.7% | +31.0% |
| 6 months | −8.7% | +8.0% |
| Year to date | +112.7% | +95.2% |
| 1 year | +65.9% | +10.3% |
| Revenue growth (YoY) | +9.2% | −100.0% |
| Gross margin | 100.0% | — |
| Net margin | −1448.6% | — |
| P/E (TTM) | — | — |
| Price / sales | 38.6× | — |
| Net cash | $153.8M | $65.1M |
| Dividend yield | — | — |
| Volatility (60d) | 56.4% | 70.1% |
| Short % of float | 10.4% | 9.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).